Indications
Therapeutic Asset Ratings
5,098 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Asparaginase
Myeloproliferative Neoplasm
Children's Oncology Group
P3
B
(60)
Aspirin
Breast Cancer
The Christie NHS Foundation Trust
P3
B
(60)
Aspirin
Heart Disorder
Assistance Publique - Hôpitaux de Paris
P3
B
(60)
Aspirin
Rheumatic Heart Disease
Population Health Research Institute
P3
B
(60)
Asundexian
Stroke Disorder
Bayer
P3
B
(60)
Atebimetinib
Pancreatic Adenocarcinoma
Immuneering Corporation
P3
B
(60)
Atebimetinib
Pancreatic Neoplasm
Immuneering Corporation
P3
B
(60)
Atebimetinib
Malignant Pancreatic Neoplasm
Immuneering Corporation
P3
B
(60)
Atebimetinib
Pancreatic Ductal Adenocarcinoma
Immuneering Corporation
P3
B
(60)
Atezolizumab
Breast Cancer
The Netherlands Cancer Institute
P3
B
(60)
Atezolizumab
Bladder Transitional Cell Carcinoma
KaliVir Immunotherapeutics
P3
B
(60)
Atezolizumab
Urethra Transitional Cell Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(60)
Atezolizumab
Venous Thromboembolism
Jia Fan
P3
B
(60)
Atorvastatin
Intracranial Arteriosclerosis
The First Affiliated Hospital with Nanjing Medical University
P3
B
(60)
Avelumab
Non-Small Cell Lung Carcinoma
Fate Therapeutics
P3
B
(60)
Axitinib
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(60)
Axitinib
Non-Small Cell Lung Carcinoma
Shanghai Pulmonary Hospital, Shanghai, China
P3
B
(60)
Axitinib
Urothelial Carcinoma
Pfizer
P3
B
(60)
Azacitidine
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)
P3
B
(60)
Baricitinib
Long COVID-19
Vanderbilt University Medical Center
P3
B
(60)
Begev
Classic Hodgkin Lymphoma
Cairo University
P3
B
(60)
Bel-Sar
Malignant Choroid Melanoma
Aura Biosciences
P3
B
(60)
Bel-Sar
Ocular Melanoma
Aura Biosciences
P3
B
(60)
Benmelstobart
Kidney Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P3
B
(60)
Benmelstobart
Non-Small Cell Squamous Lung Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P3
B
(60)
Showing 2801 to 2825 of 5,098 assets
Previous
Page 113 of 204
Next